4C LABS is a rapidly scaling healthcare, technology and pharmaceutical start-up focused on virtual prescribing, pharmaceutical distribution and clinical development in cannabis based medicinal products for human health.
The empirical evidence for the efficacy of CBPM's as a therapeutic agent in the treatment of cancer related pain, anxiety, childhood epilepsy, spasticity and sleep disorders is now overwhelming.
We are committed to advancing scientific research, as well as enabling the regulation, distribution and prescribing of CBPM's in the UK and Channel Islands.
Our work with leading scientists, specialist physicians and pharmacists is underpinned with disruptive technologies that are driving an approach to treatment that prioritizes patients and evidence over stigma.
We work closely with Drug Science, the Cannabis Industry Council, The Home Office, The Medicines and Healthcare and regulatory Authority and the Care Quality Commission to catalyse safe, regulated change in the medical landscape.
If you are a technologist, physician, scientist, distributor, LP or a patient and are interested in working with us, get in touch for a conversation: [email protected]
-
Industrie
-
Health and Human Services
-
Größe des Unternehmens
-
51-200 Mitarbeiter
-
Hauptsitz
-
London, London
-
Typ
-
In Privatbesitz
-
Gegründet
-
2018
-
Spezialitäten
-
Disruptive Technology , Virtual Clinics, Wholesale Distributor , CBPM's, Pharmaceutical Manufacturer, GMP / GDP, and Medical Cannabis
